MX2023003278A - Generacion de una linea celular de ovario de hamster chino recombinante de alta produccion para la produccion de proteinas terapeuticas. - Google Patents

Generacion de una linea celular de ovario de hamster chino recombinante de alta produccion para la produccion de proteinas terapeuticas.

Info

Publication number
MX2023003278A
MX2023003278A MX2023003278A MX2023003278A MX2023003278A MX 2023003278 A MX2023003278 A MX 2023003278A MX 2023003278 A MX2023003278 A MX 2023003278A MX 2023003278 A MX2023003278 A MX 2023003278A MX 2023003278 A MX2023003278 A MX 2023003278A
Authority
MX
Mexico
Prior art keywords
cell line
generation
producing recombinant
chinese hamster
hamster ovary
Prior art date
Application number
MX2023003278A
Other languages
English (en)
Inventor
Bruno Louis Dumas
Mohammed Nabil Lounis
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of MX2023003278A publication Critical patent/MX2023003278A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
    • C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y103/00—Oxidoreductases acting on the CH-CH group of donors (1.3)
    • C12Y103/05—Oxidoreductases acting on the CH-CH group of donors (1.3) with a quinone or related compound as acceptor (1.3.5)
    • C12Y103/05002—Dihydroorotate dehydrogenase (1.3.5.2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y603/00—Ligases forming carbon-nitrogen bonds (6.3)
    • C12Y603/01—Acid-ammonia (or amine)ligases (amide synthases)(6.3.1)
    • C12Y603/01002—Glutamate-ammonia ligase (6.3.1.2)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPRs]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Reproductive Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invención se refiere a una línea celular que comprende los genes endógenos de dihidroorotato deshidrogenasa (DHODH) y glutamina sintetasa (GS) que están parcial o totalmente inactivados, y su uso para producir proteínas recombinantes.
MX2023003278A 2020-09-21 2021-09-21 Generacion de una linea celular de ovario de hamster chino recombinante de alta produccion para la produccion de proteinas terapeuticas. MX2023003278A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20306068 2020-09-21
PCT/EP2021/075864 WO2022058603A1 (en) 2020-09-21 2021-09-21 Generation of a high producing recombinant chinese hamster ovary cell line for therapeutic protein production

Publications (1)

Publication Number Publication Date
MX2023003278A true MX2023003278A (es) 2023-04-12

Family

ID=72840426

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023003278A MX2023003278A (es) 2020-09-21 2021-09-21 Generacion de una linea celular de ovario de hamster chino recombinante de alta produccion para la produccion de proteinas terapeuticas.

Country Status (12)

Country Link
US (1) US20240043878A1 (es)
EP (1) EP4214308A1 (es)
JP (1) JP2023544267A (es)
KR (1) KR20230068401A (es)
CN (1) CN116457468A (es)
AU (1) AU2021342718A1 (es)
BR (1) BR112023005002A2 (es)
CA (1) CA3195524A1 (es)
IL (1) IL301442A (es)
MX (1) MX2023003278A (es)
TW (1) TW202227622A (es)
WO (1) WO2022058603A1 (es)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
KR100267720B1 (ko) 1997-12-29 2001-03-02 박호군 사람 글루타민 합성효소 유전자를 포함하는 발현벡터 및 이를 이용하여 동물세포에서 에리트로포이에틴을 고수율로 생산하는 방법
US20030166201A1 (en) * 2001-04-30 2003-09-04 Jensen Michael C. Selection systems for genetically modified cells
EP2674495A1 (en) 2012-06-14 2013-12-18 Sanofi CHO expression system
SG11201702516UA (en) 2014-10-23 2017-04-27 Sanofi Sa Novel selection marker for cell transfection and protein production
EP3821027A1 (en) * 2018-07-13 2021-05-19 Enzene Biosciences Ltd. Double knock-out cho cell line method of its generation and producing therapeutic proteins therefrom
BR112021018124A2 (pt) * 2019-03-19 2021-11-16 Sanofi Sa Linhagem celular compreendendo marcador de seleção e usos do mesmo para produção de proteína
WO2020243642A2 (en) * 2019-05-31 2020-12-03 The Trustees Of Columbia University In The City Of New York Multiply auxotrophic cell line for the production of recombinant proteins and methods thereof

Also Published As

Publication number Publication date
TW202227622A (zh) 2022-07-16
IL301442A (en) 2023-05-01
EP4214308A1 (en) 2023-07-26
KR20230068401A (ko) 2023-05-17
CA3195524A1 (en) 2022-03-24
BR112023005002A2 (pt) 2023-04-18
AU2021342718A1 (en) 2023-06-08
JP2023544267A (ja) 2023-10-23
US20240043878A1 (en) 2024-02-08
WO2022058603A1 (en) 2022-03-24
CN116457468A (zh) 2023-07-18

Similar Documents

Publication Publication Date Title
MX2018011928A (es) Linea celular para produccion de proteina recombinante y/o vector viral.
PH12018501055A1 (en) Cpg reduced factor viii variants, compositions and methods and uses for treatment of hemostasis disorders
MX2021013380A (es) Proteinas policlonales recombinantes y metodos de uso de las mismas.
MX2020000294A (es) Metodos y sistemas para regular condicionalmente la expresion genica.
WO2020061229A3 (en) Arc-based capsids and uses thereof
MX2018012866A (es) Composiciones y metodos para generar anticuerpos basado en el uso de un locus potenciador de la expresion.
HK1137481A1 (en) A novel vector and expression cell line for mass production of recombinant protein and a process of producing recombinant protein using same
BR0114373A (pt) Célula hospedeira eucariótica, métodos para a produção de fvii e de fviia ou de suas variantes, de uma proteìna dependente de vitamina k e de uma célula hospedeira eucariótica produtora de fvii ou de seu análogo, vetor recombinante, fvii e fviia recombinante ou suas variantes, e, proteìna dependente de vitamina k recombinante
MX2020007024A (es) Sialidasas humanas recombinantes, proteinas de fusion de sialidasa y metodos para usar las mismas.
EP4273248A3 (en) Destabilising domains for conditionally stabilising a protein
Smolskaya et al. Enhanced yield of recombinant proteins with site-specifically incorporated unnatural amino acids using a cell-free expression system
MX2023003278A (es) Generacion de una linea celular de ovario de hamster chino recombinante de alta produccion para la produccion de proteinas terapeuticas.
MX2023001595A (es) Proteinas de fusion que comprenden proteinas de leche y composiciones de las mismas.
MX2022014162A (es) Proteínas de fusión de la proteína de la espícula del coronavirus estabilizadas.
NZ760107A (en) Methods and compositions for promoting non-natural amino acid-containing protein production
MX2020013296A (es) Composiciones que contienen inhibidor de proteasa recombinante, metodos para producir las mismas y usos de las mismas.
MX2021013743A (es) Subunidad s1 modificada de la proteina de espicula de coronavirus.
BR112022008214A2 (pt) Composições e métodos para tratar perda auditiva neurossensorial usando sistemas de vetor duplo de otoferlina
MX2021008550A (es) Vectores viricos que codifican variantes del factor anti-hemofilico a (fviii) recombinantes con mayor expresion para la genoterapia de la hemofilia a.
EP4100534A4 (en) SYNTHETIC DNA CONSTRUCTS FOR REGULATING SIGNAL PEPTIDE PERFORMANCE AND VECTORS, HOST CELLS AND RECOMBINANT PROTEINS THEREOF
WO2019074292A3 (ko) 고발현 및 고기능성 목적 단백질의 생산을 위한 발현 카세트 및 이의 이용
MX2021011303A (es) Nueva linea celular que comprende marcador de seleccion y usos de la misma para la produccion de proteinas.
MX2023005896A (es) Variantes de anticuerpos bovinos.
MX2022006385A (es) Acidos nucleicos, vectores, celulas huespedes y metodos para la produccion de beta-fructofuranosidasa a partir de aspergillus niger.
ATE532861T1 (de) Expressionsvektor